iconoclast's Recent Posts
Title ▼ Rating Company Posted on
Re: The synergy of rosuvastatin (Crestor) with apabetalone 3 Resverlogix Corp. Oct 07, 2019 03:21PM
Re: The synergy of rosuvastatin (Crestor) with apabetalone 5 Resverlogix Corp. Oct 05, 2019 10:53PM
Re: The synergy of rosuvastatin (Crestor) with apabetalone 4 Resverlogix Corp. Oct 05, 2019 11:56PM
Re: The synergy of rosuvastatin (Crestor) with apabetalone 5 Resverlogix Corp. Oct 06, 2019 07:59AM
Re: The synergy of rosuvastatin (Crestor) with apabetalone 4 Resverlogix Corp. Oct 06, 2019 10:14AM
Re: The synergy of rosuvastatin (Crestor) with apabetalone 1 Resverlogix Corp. Oct 03, 2019 09:55AM
Re: The runway is clear.... 1 Resverlogix Corp. Dec 07, 2018 11:31AM
Re: The runway is clear.... 6 Resverlogix Corp. Dec 08, 2018 10:42AM
Re: The last couple of minutes of Tax Loss Selling 1 Resverlogix Corp. Dec 30, 2019 10:56AM
Re: The last couple of minutes of Tax Loss Selling 1 Resverlogix Corp. Dec 30, 2019 12:03PM
Re: The HDL hypothesis lives on 3 Resverlogix Corp. Dec 18, 2018 09:51PM
Re: The Evolution of Apabetalone, Redux 3 Resverlogix Corp. Apr 26, 2019 05:28PM
Re: The chart set up looks awesome imo.... 4 Resverlogix Corp. Dec 03, 2019 12:46PM
Re: The chart set up looks awesome imo.... 3 Resverlogix Corp. Dec 03, 2019 01:11PM
Re: The chart set up looks awesome imo.... 6 Resverlogix Corp. Dec 03, 2019 04:08PM
Re: Technically we're very oversold... 5 Resverlogix Corp. Dec 17, 2019 03:37PM
Re: Technically we're very oversold... 2 Resverlogix Corp. Dec 17, 2019 03:53PM
Re: Technically we're very oversold... Resverlogix Corp. Dec 17, 2019 05:19PM
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia Resverlogix Corp. Aug 29, 2019 11:09AM
Re: Take Home Points: not ready for use in patients 8 Resverlogix Corp. Nov 16, 2019 04:06PM